Retroviral vectors for delivery of interfering RN

Details for Australian Patent Application No. 2009248456 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Grueneberg, Dorre; Bain, Gerard; Kothari, Nayantara

Agent Watermark

Pub. Number AU-B-2009248456

Parent 2004286231

Filing date 9 December 2009

Wipo publication date 7 January 2010

Acceptance publication date 15 September 2011

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

Event Publications

7 January 2010 Application Open to Public Inspection

  Published as AU-B-2009248456

7 January 2010 Complete Application Filed

15 September 2011 Application Accepted

  Published as AU-B-2009248456

10 November 2011 Application for Amendment

  The nature of the amendment is: Amend the invention title to read Retroviral vectors for delivery of interfering RNA. Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122 2010

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

1 March 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Retroviral vectors for delivery of interfering RNA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009248457-Dual seal with bellows

2009248455-3, 10, and 12a substituted tetracycline compounds